Drug information for AGRYLIN

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
CAPSULE; ORAL	EQ 0.5MG BASE	Prescription	AB	ANAGRELIDE HYDROCHLORIDE	anagrelide	SHIRE LLC	20333 2011-11-30 Label 2011-11-28 Letter 2011-02-04 Letter 2011-01-31 Label 2010-07-06 Label 2010-07-02 Letter 2009-07-23 Label 2009-07-17 Letter 2008-06-20 Letter 2008-06-19 Label 2004-12-30 Letter 2004-12-30 Label 2004-12-10 Label 2004-12-10 Letter 2004-12-10 Label 2004-12-10 Letter 1998-12-16 Letter 1998-12-16 Review 1998-12-16 Label
CAPSULE; ORAL	EQ 1MG BASE	Discontinued		ANAGRELIDE HYDROCHLORIDE	anagrelide	SHIRE LLC	"

Drug Adverse Effects information for AGRYLIN

Role code	Indications	Reaction	# Reports
PS	PRODUCT USED FOR UNKNOWN INDICATION	DRUG DIVERSION	1
PS	PRODUCT USED FOR UNKNOWN INDICATION	INTENTIONAL OVERDOSE	1
C	MYELODYSPLASTIC SYNDROME	DRUG INEFFECTIVE	1

Ads by Google